Showing posts with label Age-Related Macular Degeneration Market. Show all posts
Showing posts with label Age-Related Macular Degeneration Market. Show all posts

What is Age-Related Macular Degeneration?

 Age-related macular degeneration (AMD) is an eye illness that can have an adverse impact or blur your vision. It usually occurs after a person attains a certain age — the portion of the eye that controls straight-ahead vision. The macula is a portion of the retina which is the light-sensitive tissue at the back of the eye.

Age-related macular degeneration is a common disorder —it is one of the leading reasons for vision loss for older people. AMD causes partial blindness, not complete blindness, but losing the central vision will be going to make it hard to recognize any face or thing at the first glance, read, drive or do work such as household work, and cooking.

Age-related macular degeneration is an ailment that grows relatively slowly. It is possible that if you are suffering from early AMD, you would not even notice that, you losing any vision for a long time. That’s why it’s vital to get regular eye check-ups to find out if you have AMD.

Types and Stages of Age-Related Macular Degeneration

There are mainly two types of AMD dry and wet

Dry AMD - Most people suffering from AMD have dry AMD. This happens when the macula starts to deplete with age. Dry AMD happens in three stages: early, intermediate, and late. It usually progresses slowly over the period of several years. There’s no treatment for late dry AMD, but you can find ways to save your remaining vision. And if you are suffering from late dry AMD in only 1 eye, then you can take steps to guard your other eye.

Wet AMD - It is known as advanced neovascular AMD, this is not that common, and it grows at a faster pace in comparison to dry AMD. Dry AMD can turn into wet AMD. It occurs when abnormal blood vessels accumulate at the back the eye and harms the macula. But the only good thing about wet AMD is that the cure is available. 

Only a limited number of medications are licensed to cure this illness, habitually by anti-VEGFs. Such medicines require regular and uncomfortable intraocular injections, which improves the strain and source non-adherence to treatment. 

How Can you Lower the Risk for AMD?

You can lower the risk of AMD (or slow vision loss from AMD) by making these healthy choices: 

Don’t smoke 

Do regular physical exercise 

Keep blood pressure and cholesterol levels in check

Eat healthy foods, like leafy green vegetables and fish

What are the Symptoms of Macular Degeneration 

Blur central vision., and it may be tough to read fine print or drive. Dark, blurry parts in the center of your eye vision.

Sometimes not able to distinguish between different colors. 

Hence, as the population across the world is getting old and by 2040 around 22% of the world's population will be over 60 years. So, with the growing elderly population, AMD illness will also increase, contributing to the growth of the AMD industry. 



Share:

Age-Related Macular Degeneration Market Segmental Analysis by Therapeutics, Diagnostics, Patent, Drugs Policy and Regulatory Landscape


The market is experiencing growth due to the rising geriatric population, growing pipeline for AMD therapeutics, surging chronic disease prevalence, and increasing healthcare expenditure. Age-related macular degeneration is a retinal disorder, which is indicated by changes in the fundus of the eye. It commonly affects the elderly, in which, first, the central vision becomes blurred, which ultimately leads to blindness.
The age-related macular degeneration market is classified into Asia-Pacific, Europe, North America, and Rest of the World, based on region. In 2015, the highest value share in the market was held by the North American region. This was attributed to the rising prevalence of conditions, such as obesity and hypertension. Further, the presence of major pharmaceutical companies supports the regional market growth. In 2022, with high healthcare expenditure of countries in the region, it is predicted to hold more than 90.0% of the market share.
Download Report Sample at:
The age-related macular degeneration market is growing due to the rising geriatric population. Old age is one of the major risk factors of the disease, which may lead to visual impairment, and eventually complete blindness. A report on global aging population was published by the United Nations Department of Economic and Social Affairs, which mentioned that the global population of people in the 60 and above age group, is growing at a high rate. The share of geriatric population by 2050 is predicted to grow to 21.1% from 11.7% in 2013.

Therefore, the market for AMD is predicted to register remarkable growth in the forecast period with the rising prevalence of this disease and surging geriatric population.

Share:

Popular Posts